192 related articles for article (PubMed ID: 23526831)
1. Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.
Lim SM; Chen D; Teo H; Roos A; Jansson AE; Nyman T; Trésaugues L; Pervushin K; Nordlund P
J Lipid Res; 2013 Jun; 54(6):1630-1643. PubMed ID: 23526831
[TBL] [Abstract][Full Text] [Related]
2. NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity.
Shimamoto S; Yoshida T; Inui T; Gohda K; Kobayashi Y; Fujimori K; Tsurumura T; Aritake K; Urade Y; Ohkubo T
J Biol Chem; 2007 Oct; 282(43):31373-9. PubMed ID: 17715133
[TBL] [Abstract][Full Text] [Related]
3. Substrate-induced product-release mechanism of lipocalin-type prostaglandin D synthase.
Shimamoto S; Nakagawa Y; Hidaka Y; Maruno T; Kobayashi Y; Kawahara K; Yoshida T; Ohkubo T; Aritake K; Kaushik MK; Urade Y
Biochem Biophys Res Commun; 2021 Sep; 569():66-71. PubMed ID: 34237429
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of lipocalin-type prostaglandin D synthase complexed with biliverdin by small-angle X-ray scattering and multi-dimensional NMR.
Miyamoto Y; Nishimura S; Inoue K; Shimamoto S; Yoshida T; Fukuhara A; Yamada M; Urade Y; Yagi N; Ohkubo T; Inui T
J Struct Biol; 2010 Feb; 169(2):209-18. PubMed ID: 19833210
[TBL] [Abstract][Full Text] [Related]
5. ¹H, ¹³C, and ¹⁵N resonance assignments of mouse lipocalin-type prostaglandin D synthase/substrate analog complex.
Shimamoto S; Maruo H; Yoshida T; Ohkubo T
Biomol NMR Assign; 2014 Apr; 8(1):129-32. PubMed ID: 23361378
[TBL] [Abstract][Full Text] [Related]
6. [Ligand recognition mechanism of lipocalin-type prostaglandin D synthase].
Shimamoto S; Yoshida T; Ohkubo T
Yakugaku Zasshi; 2011; 131(11):1575-81. PubMed ID: 22041695
[TBL] [Abstract][Full Text] [Related]
7. NMR resonance assignments of mouse lipocalin-type prostaglandin D synthase/prostaglandin J
Shimamoto S; Nakahata Y; Hidaka Y; Yoshida T; Ohkubo T
Biomol NMR Assign; 2022 Oct; 16(2):225-229. PubMed ID: 35445291
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic and NMR analyses of NADPH binding to lipocalin-type prostaglandin D synthase.
Qin S; Shimamoto S; Maruno T; Kobayashi Y; Kawahara K; Yoshida T; Ohkubo T
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):234-9. PubMed ID: 26518650
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of cysteine mutation isoforms of rat lipocalin-type prostaglandin D synthase for nuclear magnetic resonance study.
Liu J; Lin K; Guo C; Gao H; Yao Y; Lin D
Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):489-96. PubMed ID: 18535747
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase.
Kumasaka T; Aritake K; Ago H; Irikura D; Tsurumura T; Yamamoto M; Miyano M; Urade Y; Hayaishi O
J Biol Chem; 2009 Aug; 284(33):22344-22352. PubMed ID: 19546224
[TBL] [Abstract][Full Text] [Related]
11. NMR assignment of 1H, 13C, and 15N resonances of rat lipocalin-type prostaglandin D synthase.
Liu J; Lv Y; Guo C; Lin D
Biomol NMR Assign; 2010 Oct; 4(2):223-5. PubMed ID: 20617402
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of human l-prostaglandin D synthase bound with fatty acid molecules.
Zhou Y; Shaw N; Li Y; Zhao Y; Zhang R; Liu ZJ
FASEB J; 2010 Dec; 24(12):4668-77. PubMed ID: 20667974
[TBL] [Abstract][Full Text] [Related]
13. High-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase.
Perduca M; Bovi M; Bertinelli M; Bertini E; Destefanis L; Carrizo ME; Capaldi S; Monaco HL
Acta Crystallogr D Biol Crystallogr; 2014 Aug; 70(Pt 8):2125-38. PubMed ID: 25084332
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin-type prostaglandin D synthase protects against oxidative stress-induced neuronal cell death.
Fukuhara A; Yamada M; Fujimori K; Miyamoto Y; Kusumoto T; Nakajima H; Inui T
Biochem J; 2012 Apr; 443(1):75-84. PubMed ID: 22248185
[TBL] [Abstract][Full Text] [Related]
15. Structural and interaction analysis of human lipocalin-type prostaglandin D synthase with the poorly water-soluble drug NBQX.
Miyamoto Y; Nakatsuji M; Yoshida T; Ohkubo T; Inui T
FEBS J; 2023 Aug; 290(16):3983-3996. PubMed ID: 37021622
[TBL] [Abstract][Full Text] [Related]
16. Identification of the residues in the helix F/G loop important to catalytic function of membrane-bound prostacyclin synthase.
Deng H; Wu J; So SP; Ruan KH
Biochemistry; 2003 May; 42(19):5609-17. PubMed ID: 12741817
[TBL] [Abstract][Full Text] [Related]
17. Effects of removing a conserved disulfide bond on the biological characteristics of rat lipocalin-type prostaglandin D synthase.
Liu J; Guo C; Yao Y; Lin D
Biochimie; 2008; 90(11-12):1637-46. PubMed ID: 18590794
[TBL] [Abstract][Full Text] [Related]
18. Fine-tuned broad binding capability of human lipocalin-type prostaglandin D synthase for various small lipophilic ligands.
Kume S; Lee YH; Nakatsuji M; Teraoka Y; Yamaguchi K; Goto Y; Inui T
FEBS Lett; 2014 Mar; 588(6):962-9. PubMed ID: 24530534
[TBL] [Abstract][Full Text] [Related]
19. Human hematopoietic prostaglandin D synthase inhibitor complex structures.
Kado Y; Aritake K; Uodome N; Okano Y; Okazaki N; Matsumura H; Urade Y; Inoue T
J Biochem; 2012 Apr; 151(4):447-55. PubMed ID: 22418579
[TBL] [Abstract][Full Text] [Related]
20. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase.
Urade Y; Hayaishi O
Biochim Biophys Acta; 2000 Oct; 1482(1-2):259-71. PubMed ID: 11058767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
